Pediapharm Announces Death of Director

MONTREAL, QUEBEC–(Marketwired – Nov. 29, 2017) - Pediapharm Inc. (TSX VENTURE:PDP) (the “Company” or “Pediapharm”) announces with great sadness that Mr. Douglas M. Stuve, an independent member of the Company’s Board of Directors, passed away on November 23, 2017. Mr. Stuve was appointed in 2013 and was the Chair of the Company’s Compensation, Corporate Governance and Nominating Committee.

“First and foremost, on behalf of the Board of Directors and the entire Pediapharm team, we want to extend our deepest sympathies to Doug’s family”, stated Mr. Pierre Lapalme, the Company’s Chairman. “In addition to being a good friend, he was a valued member of the Pediapharm family and we are forever grateful for his contributions”.

About Pediapharm Inc.

Pediapharm is the only Canadian specialty pharmaceutical company dedicated to serving the needs of the pediatric community. Its mission is to bring to the Canadian market the latest innovative pediatric products with the objective to improve the health and the well-being of children in Canada.

Pediapharm Inc.
Sylvain Chretien
President and Chief Executive Officer
514-762-2626 ext. 201

Pediapharm Inc.
Roland Boivin
Chief Financial Officer
514-762-2626 ext. 202

Frank Candido
Direct Financial Strategies and Communication Inc.